SUSQUEHANNA INTERNATIONAL GROUP, LLP - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$24,000
-97.6%
121,204
-71.3%
0.00%
Q1 2018$986,000
-26.5%
422,847
-10.6%
0.00%
Q4 2017$1,342,000
+1.9%
472,781
+2.7%
0.00%
Q3 2017$1,317,000
+186.9%
460,538
+147.5%
0.00%
Q2 2017$459,000
-27.9%
186,073
+5.5%
0.00%
Q1 2017$637,000
-72.8%
176,449
-73.3%
0.00%
Q4 2016$2,339,000
-10.6%
660,671
+2.1%
0.00%
-100.0%
Q3 2016$2,615,000
-13.3%
647,300
-5.8%
0.00%0.0%
Q2 2016$3,015,000
-9.8%
686,841
-22.4%
0.00%0.0%
Q1 2016$3,344,000
-88.1%
884,553
-50.6%
0.00%
-84.6%
Q4 2015$28,098,000
+48.1%
1,791,957
-0.4%
0.01%
+44.4%
Q3 2015$18,968,000
-62.3%
1,799,558
-9.8%
0.01%
-57.1%
Q2 2015$50,291,000
-21.7%
1,994,093
-13.4%
0.02%
-27.6%
Q1 2015$64,198,000
+43.1%
2,303,482
-6.3%
0.03%
+61.1%
Q4 2014$44,850,000
+38.8%
2,457,488
-1.4%
0.02%
+50.0%
Q3 2014$32,312,000
-24.7%
2,493,135
-5.2%
0.01%
-33.3%
Q2 2014$42,904,000
+31.9%
2,628,898
+42.9%
0.02%
+20.0%
Q1 2014$32,517,000
-0.0%
1,840,253
+36.9%
0.02%0.0%
Q4 2013$32,533,000
-32.7%
1,343,775
-1.6%
0.02%
-40.0%
Q3 2013$48,360,000
+276.6%
1,364,943
+65.9%
0.02%
+257.1%
Q2 2013$12,842,000822,6460.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders